Advertisement

Prevalence and Risk Factors for Drug-Related Problems in People With Dementia Living in the Community: A Systematic Review and Meta-Analysis

      Abstract

      Objectives

      The aims of this systematic review were to identify the prevalence and risk factors associated with drug-related problems (DRPs) in people living with dementia in the community.

      Design

      A systematic review and meta-analysis.

      Setting and Participants

      People with dementia living in the community.

      Methods

      Six databases (Embase, Medline, PsycINFO, International Pharmaceutical Abstracts, Scopus, and CINAHL) were searched using a combination of keywords and Medical Subject Heading (MeSH) terms with 4 concepts: dementia, older adults, DRPs, and community-dwelling. Primary outcomes were adverse drug reactions (ADRs), adverse drug events (ADEs), and medication errors (MEs).

      Results

      There were 22 studies included: 4 cross-sectional studies and 18 cohort studies. The number of participants in these studies ranged from 81 to 21,795. The pooled prevalence for any ADEs, including ADRs, in people living with dementia was 19.0% (95% CI 11.6%-27.7%), whereas the pooled prevalence for specific types of ADEs ranged from 2.6% to 10.2%. Furthermore, the prevalence of MEs ranged from 0.9% to 41.3%. Psychotropic medications, polypharmacy, and inappropriate medications contributed to an increased risk of experiencing DRPs, whereas support with medication management was a protective factor.

      Conclusions and Implications

      The prevalence of overall DRPs experienced by people with dementia was highly variable in included studies. Awareness that certain medication, patient, and medication management factors are associated with the risk of people with dementia experiencing DRPs may guide clinicians to identify high-risk situations and implement suitable mitigation strategies.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • World Health Organization
        Dementia. International Classification of Diseases 11th Revision for Mortality and Morbidity Statistics (ICD-11 MMS).
        2020 (World Health Organization)
        • Australian Institute of Health and Welfare
        Dementia in Australia 2021: Summary Report.
        2021 (Australian Institute of Health and Welfare)
        • Australian Bureau of Statistics
        Dementia in Australia.
        2020 (Australian Bureau of Statistics)
        • World Health Organization
        Dementia.
        2020 (Accessed August 30, 2021)
        • Arlt S.
        • Lindner R.
        • Rösler A.
        • et al.
        Adherence to medication in patients with dementia.
        Drugs Aging. 2008; 25: 1033-1047
        • Leporini C.
        • De Sarro G.
        • Russo E.
        Adherence to therapy and adverse drug reactions: is there a link?.
        Exp Opin Drug Saf. 2014; 13: 41-55
        • Clague F.
        • Mercer S.W.
        • McLean G.
        • et al.
        Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data.
        Age Ageing. 2017; 46: 33-39
        • Doraiswamy P.M.
        • Leon J.
        • Cummings J.L.
        • et al.
        Prevalence and impact of medical comorbidity in Alzheimer's disease.
        J Gerontol A Biol Sci Med Sci. 2002; 57: M173-M177
        • Lavan A.H.
        • Gallagher P.
        Predicting risk of adverse drug reactions in older adults.
        Ther Adv Drug Saf. 2016; 7: 11-22
        • Schubert C.C.
        • Boustani M.
        • Callahan C.M.
        • et al.
        Comorbidity profile of dementia patients in primary care: are they sicker?.
        J Am Geriatr Soc. 2006; 54: 104-109
        • van Dijk P.
        • Dippel D.
        • van der Meulen J.
        • et al.
        Comorbidity and its effect on mortality in nursing home patients with dementia.
        J Nerv Ment Dis. 1996; 184: 180-187
        • Haaksma M.L.
        • Vilela L.R.
        • Marengoni A.
        • et al.
        Comorbidity and progression of late onset Alzheimer’s disease: a systematic review.
        PloS One. 2017; 12: e0177044
        • Lim R.H.
        • Sharmeen T.
        Medicines management issues in dementia and coping strategies used by people living with dementia and family carers: a systematic review.
        Int J Geriatr Psychiatry. 2018; 33: 1562-1581
        • Smith D.
        • Lovell J.
        • Weller C.
        • et al.
        A systematic review of medication non-adherence in persons with dementia or cognitive impairment.
        PloS One. 2017; 12: e0170651
        • Wojt I.R.
        • Cairns R.
        • Tan E.C.
        Poisoning exposures in people with dementia (2014‒2019): a retrospective study.
        J Am Med Dir Assoc. 2021; 22: 1553-1557.e1551
        • Shepherd H.
        • Livingston G.
        • Chan J.
        • et al.
        Hospitalisation rates and predictors in people with dementia: a systematic review and meta-analysis.
        BMC Med. 2019; 17: 130
        • Andrews J.
        A guide to creating a dementia-friendly ward.
        Nurs Times. 2013; 109: 20-21
        • Sampson E.L.
        • Blanchard M.R.
        • Jones L.
        • et al.
        Dementia in the acute hospital: prospective cohort study of prevalence and mortality.
        Br J Psychiatry. 2009; 195: 61-66
        • Timmons S.
        • O’Shea E.
        • O’Neill D.
        • et al.
        Acute hospital dementia care: results from a national audit.
        BMC Geriatr. 2016; 16: 1-10
        • Sakiris M.A.
        • Sawan M.
        • Hilmer S.N.
        • et al.
        Prevalence of adverse drug events and adverse drug reactions in hospital among older patients with dementia: a systematic review.
        Br J Clin Pharmacol. 2021; 87: 375-385
        • Zaidi A.S.
        • Peterson G.M.
        • Bereznicki L.R.
        • et al.
        Outcomes of medication misadventure among people with cognitive impairment or dementia: a systematic review and meta-analysis.
        Ann Pharmacother. 2021; 55: 530-542
        • Edwards I.R.
        • Aronson J.K.
        Adverse drug reactions: definitions, diagnosis, and management.
        Lancet. 2000; 356: 1255-1259
        • Aronson J.K.
        Medication errors: what they are, how they happen, and how to avoid them.
        QJM. 2009; 102: 513-521
        • van den Bemt P.M.
        • Egberts A.
        Drug related problems: definitions and classification.
        EJHP Pract. 2007; 2007: 62-64
        • Munn Z.
        • Moola S.
        • Lisy K.
        • et al.
        Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data.
        Int J Evid Based Healthc. 2015; 13: 147-153
        • Moher D.
        • Liberati A.A.
        • Tetzlaff J.
        • Altman D.G.
        Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        BMJ. 2009; 339: b2535
        • Laroche M.L.
        • Perault-Pochat M.C.
        • Ingrand I.
        • et al.
        Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study.
        Pharmacoepidemiol Drug Saf. 2013; 22: 952-960
        • Wucherer D.
        • Thyrian J.R.
        • Eichler T.
        • et al.
        Drug-related problems in community-dwelling primary care patients screened positive for dementia.
        Int Psychogeriatr. 2017; 29: 1857-1868
        • Ferreira T.R.
        • Lopes L.C.
        • Bergamaschi C.D.C.
        Frequency and severity of adverse drug reactions to medications prescribed for Alzheimer’s disease in a Brazilian city: cross-sectional study.
        Front Pharmacol. 2020; 11: 538095
        • Imai H.
        • Hirai T.
        • Kumazawa R.
        • et al.
        Prevalence of and risk factors for adverse events in Alzheimer's patients receiving anti-dementia drugs in at-home care.
        PloS One. 2020; 15: e0231226
        • Fick D.
        • Kolanowski A.
        • Waller J.
        High prevalence of central nervous system medications in community-dwelling older adults with dementia over a three-year period.
        Aging Ment Health. 2007; 11: 588-595
        • Rochon P.A.
        • Normand S.L.
        • Gomes T.
        • et al.
        Antipsychotic therapy and short-term serious events in older adults with dementia.
        Arch Intern Med. 2008; 168: 1090-1096
        • Froelich L.
        • Andreasen N.
        • Tsolaki M.
        • et al.
        Long-term treatment of patients with Alzheimer's disease in primary and secondary care: results from an international survey.
        Curr Med Res Opin. 2009; 25: 3059-3068
        • Gill S.S.
        • Anderson G.M.
        • Fischer H.D.
        • et al.
        Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.
        Arch Intern Med. 2009; 169: 867-873
        • Stephenson A.
        • Seitz D.P.
        • Fischer H.D.
        • et al.
        Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study.
        Drugs Aging. 2012; 29: 213-223
        • Fiss T.
        • Thyrian J.R.
        • Fendrich K.
        • et al.
        Cognitive impairment in primary ambulatory health care: pharmacotherapy and the use of potentially inappropriate medicine.
        Int J Geriatr Psychiatry. 2013; 28: 173-181
        • Rafaniello C.
        • Lombardo F.
        • Ferrajolo C.
        • et al.
        Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy.
        Eur J Clin Pharmacol. 2014; 70: 187-195
        • Torvinen-Kiiskinen S.
        • Tolppanen A.M.
        • Koponen M.
        • et al.
        Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease.
        Int J Geriatr Psychiatry. 2017; 32: e107-e115
        • Taipale H.
        • Tolppanen A.-M.
        • Koponen M.
        • et al.
        Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease.
        CMAJ. 2017; 189: E519-E529
        • Taipale H.
        • Koponen M.
        • Tanskanen A.
        • et al.
        Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease, a nationwide matched cohort study.
        Eur Geriatr Med. 2017; 8: S15
        • Hyttinen V.
        • Taipale H.
        • Tolppanen A.M.
        • et al.
        Incident use of a potentially inappropriate medication and hip fracture in community-dwelling older persons with Alzheimer’s disease.
        Ann Pharmacother. 2017; 51: 725-734
        • Koponen M.
        • Taipale H.
        • Lavikainen P.
        • et al.
        Antipsychotic use and the risk of hip fracture among community-dwelling persons with Alzheimer's disease.
        J Clin Psychiatry. 2017; 78: e257-e263
        • Dennis M.
        • Shine L.
        • John A.
        • et al.
        Risk of adverse outcomes for older people with dementia prescribed antipsychotic medication: a population based e-cohort study.
        Neurol Ther. 2017; 6: 57-77
        • Sarycheva T.
        • Lavikainen P.
        • Taipale H.
        • et al.
        Risk of death in relation to antiepileptic drug use among community-dwelling persons with Alzheimer's disease: a matched cohort study.
        Eur Geriatr Med. 2019; 10: S25-S26
        • Taipale H.
        • Lampela P.
        • Koponen M.
        • et al.
        Antiepileptic drug use is associated with an increased risk of pneumonia among community-dwelling persons with Alzheimer's disease-matched cohort study.
        J Alzheimers Dis. 2019; 68: 127-136
        • Taipale H.
        • Hamina A.
        • Karttunen N.
        • et al.
        Incident opioid use and risk of hip fracture among persons with Alzheimer disease: a nationwide matched cohort study.
        Pain. 2019; 160: 417-423
        • Tapiainen V.
        • Lavikainen P.
        • Koponen M.
        • et al.
        The risk of head injuries associated with antipsychotic use among persons with Alzheimer's disease.
        J Am Geriatr Soc. 2020; 68: 595-602
        • Trinkley K.E.
        • Sturm A.M.
        • Porter K.
        • et al.
        Efficacy and safety of atypical antipsychotics for behavioral and psychological symptoms of dementia among community dwelling adults.
        J Pharm Pract. 2020; 33: 7-14
        • Ganjavi H.
        • Herrmann N.
        • Rochon P.A.
        • et al.
        Adverse drug events in cognitively impaired elderly patients.
        Dement Geriatr Cogn Disord. 2007; 23: 395-400
        • Taché S.V.
        • Sönnichsen A.
        • Ashcroft D.M.
        Prevalence of adverse drug events in ambulatory care: a systematic review.
        Ann Pharmacother. 2011; 45: 977-989
        • Banovic S.
        • Zunic L.J.
        • Sinanovic O.
        Communication difficulties as a result of dementia.
        Mater Sociomed. 2018; 30: 221-224
        • Gurwitz J.H.
        • Field T.S.
        • Judge J.
        • et al.
        The incidence of adverse drug events in two large academic long-term care facilities.
        Am J Med. 2005; 118: 251-258
        • Maust D.T.
        • Strominger J.
        • Bynum J.P.
        • et al.
        Prevalence of psychotropic and opioid prescription fills among community-dwelling older adults with dementia in the US.
        JAMA. 2020; 324: 706-708
        • Peisah C.
        • Skladzien E.
        The Use of Restraints and Psychotropic Medications in People With Dementia.
        2014 (Paper 38. Alzheimer's Australia Inc)
        • Kannus P.
        • Niemi S.
        • Parkkari J.
        • et al.
        Continuously declining incidence of hip fracture in Finland: analysis of nationwide database in 1970–2016.
        Arch Gerontol Geriatr. 2018; 77: 64-67
        • Vila-Corcoles A.
        • Ochoa-Gondar O.
        • Rodriguez-Blanco T.
        • et al.
        Epidemiology of community-acquired pneumonia in older adults: a population-based study.
        Respir Med. 2009; 103: 309-316
        • van Durme Y.M.
        • Verhamme K.M.
        • Stijnen T.
        • et al.
        Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study.
        Chest. 2009; 135: 368-377
        • Toot S.
        • Devine M.
        • Akporobaro A.
        • et al.
        Causes of hospital admission for people with dementia: a systematic review and meta-analysis.
        J Am Med Dir Assoc. 2013; 14: 463-470
        • Lehmann J.
        • Michalowsky B.
        • Kaczynski A.
        • et al.
        The impact of hospitalization on readmission, institutionalization, and mortality of people with dementia: a systematic review and meta-analysis.
        J Alzheimers Dis. 2018; 64: 735-749
        • Ioannidis I.
        • Mohammad Ismail A.
        • Forssten M.P.
        • et al.
        The mortality burden in patients with hip fractures and dementia.
        (Eur J Trauma Emerg Surg. Published online February 27, 2021)
        https://doi.org/10.1007/s00068-021-01612-4
        • Mosk C.A.
        • Mus M.
        • Vroemen J.P.
        • et al.
        Dementia and delirium, the outcomes in elderly hip fracture patients.
        Clin Interv Aging. 2017; 12: 421-430
        • Renom-Guiteras A.
        • Thürmann P.A.
        • Miralles R.
        • et al.
        Potentially inappropriate medication among people with dementia in eight European countries.
        Age Ageing. 2018; 47: 68-74
        • Redston M.R.
        • Hilmer S.N.
        • McLachlan A.J.
        • et al.
        Prevalence of potentially inappropriate medication use in older inpatients with and without cognitive impairment: a systematic review.
        J Alzheimers Dis. 2018; 61: 1639-1652
        • Kristensen R.U.
        • Nørgaard A.
        • Jensen-Dahm C.
        • et al.
        Changes in the prevalence of polypharmacy in people with and without dementia from 2000 to 2014: a nationwide study.
        J Alzheimers Dis. 2019; 67: 949-960
        • Nguyen J.K.
        • Fouts M.M.
        • Kotabe S.E.
        • et al.
        Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents.
        Am J Geriatr Pharmacother. 2006; 4: 36-41
        • Ahmed B.
        • Nanji K.
        • Mujeeb R.
        • et al.
        Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study.
        PloS One. 2014; 9: e112133
        • Fick D.M.
        • Mion L.C.
        • Beers M.H.
        • et al.
        Health outcomes associated with potentially inappropriate medication use in older adults.
        Res Nurs Health. 2008; 31: 42-51
        • Lu W.H.
        • Wen Y.W.
        • Chen L.K.
        • et al.
        Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study.
        CMAJ. 2015; 187: E130-E137
        • Sawan M.J.
        • Moga D.C.
        • Ma M.J.
        • et al.
        The value of deprescribing in older adults with dementia: a narrative review.
        Expert Rev Clin Pharmacol. 2021; 14: 1367-1382
        • Fick D.M.
        • Semla T.P.
        • Steinman M.
        • et al.
        American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults.
        J Am Geriatr Soc. 2019; 67: 674-694
        • Gnjidic D.
        • Agogo G.O.
        • Ramsey C.M.
        • et al.
        The impact of dementia diagnosis on patterns of potentially inappropriate medication use among older adults.
        J Gerontol A Biol Sci Med Sci. 2018; 73: 1410-1417
        • Thompson C.
        • Brodaty H.
        • Trollor J.
        • et al.
        Behavioral and psychological symptoms associated with dementia subtype and severity.
        Int Psychogeriatr. 2010; 22: 300-305
        • Elliott R.A.
        • Goeman D.
        • Beanland C.
        • et al.
        Ability of older people with dementia or cognitive impairment to manage medicine regimens: a narrative review.
        Curr Clin Pharmacol. 2015; 10: 213-221
        • Fogg C.
        • Griffiths P.
        • Meredith P.
        • et al.
        Hospital outcomes of older people with cognitive impairment: an integrative review.
        Int J Geriatr Psychiatry. 2018; 33: 1177-1197
        • Douglas A.
        • Letts L.
        • Richardson J.
        A systematic review of accidental injury from fire, wandering and medication self-administration errors for older adults with and without dementia.
        Arch Gerontol Geriatr. 2011; 52: e1-e10
        • Kaasalainen S.
        • Dolovich L.
        • Papaioannou A.
        • et al.
        The process of medication management for older adults with dementia.
        J Nurs Healthc Chron Illness. 2011; 3: 407-418
        • Nguyen T.A.
        • Gilmartin-Thomas J.
        • Tan E.C.K.
        • et al.
        The impact of pharmacist interventions on quality use of medicines, quality of life, and health outcomes in people with dementia and/or cognitive impairment: a systematic review.
        J Alzheimers Dis. 2019; 71: 83-96
        • Quan H.
        • Li B.
        • Duncan Saunders L.
        • et al.
        Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database.
        Health Serv Res. 2008; 43: 1424-1441

      Related Podcast

      June 15, 2022

      June 2022 Issue: Drug Prescribing Dilemmas in Geriatric Medicine

      Host: Dr. Karl Steinberg. Featuring Dr. Philip Sloane, Dr. Mallory Brown, special guest: Josh Niznik, PharmD. Recorded on May 25, 2022.

      Loading ...